YOUR BUSINESS AUTHORITY
Springfield, MO
A weight-loss treatment from Eli Lilly has been given regulatory approval by the United States and United Kingdom.
Zepbound is expected to hit store shelves in the United States later this month.
Zepbound reportedly will be a rival to Novo Nordisk's Wegovy treatment.
Read more from Reuters.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects